Tackling adherence in sickle cell disease with mHealth

Lancet Haematol. 2020 Oct;7(10):e713-e714. doi: 10.1016/S2352-3026(20)30299-4.

Authors

Jane S Hankins¹, Nirmish Shah²

Affiliations

¹ Department of Hematology, St Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: jane.hankins@stjude.org.
² Department of Pediatrics, Duke University, Durham, NC, USA.

PMID: 32976750
DOI: 10.1016/S2352-3026(20)30299-4

No abstract available

MeSH terms

Anemia, Sickle Cell / drug therapy*
Antisickling Agents / therapeutic use*
Humans
Hydroxyurea / therapeutic use*
Mobile Applications*
Patient Compliance*
Smartphone
Telemedicine*

Substances

Antisickling Agents
Hydroxyurea

Grants and funding

U01 HL133996/HL/NHLBI NIH HHS/United States